Literature DB >> 27768081

Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 2. General Practices.

Steven Mazur1, Michael R Holbrook1, Tracey Burdette1, Nicole Joselyn1, Jason Barr1, Daniela Pusl1, Laura Bollinger1, Linda Coe1, Peter B Jahrling1, Matthew G Lackemeyer1, Jiro Wada1, Jens H Kuhn2, Krisztina Janosko1.   

Abstract

Work in a biosafety level 4 (BSL-4) containment laboratory requires time and great attention to detail. The same work that is done in a BSL-2 laboratory with non-high-consequence pathogens will take significantly longer in a BSL-4 setting. This increased time requirement is due to a multitude of factors that are aimed at protecting the researcher from laboratory-acquired infections, the work environment from potential contamination and the local community from possible release of high-consequence pathogens. Inside the laboratory, movement is restricted due to air hoses attached to the mandatory full-body safety suits. In addition, disinfection of every item that is removed from Class II biosafety cabinets (BSCs) is required. Laboratory specialists must be trained in the practices of the BSL-4 laboratory and must show high proficiency in the skills they are performing. The focus of this article is to outline proper procedures and techniques to ensure laboratory biosafety and experimental accuracy using a standard viral plaque assay as an example procedure. In particular, proper techniques to work safely in a BSL-4 environment when performing an experiment will be visually emphasized. These techniques include: setting up a Class II BSC for experiments, proper cleaning of the Class II BSC when finished working, waste management and safe disposal of waste generated inside a BSL-4 laboratory, and the removal of inactivated samples from inside a BSL-4 laboratory to the BSL-2 laboratory.

Mesh:

Substances:

Year:  2016        PMID: 27768081      PMCID: PMC5092168          DOI: 10.3791/53600

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  7 in total

1.  Virus inactivation by nucleic acid extraction reagents.

Authors:  Jamie A Blow; David J Dohm; Diane L Negley; Christopher N Mores
Journal:  J Virol Methods       Date:  2004-08       Impact factor: 2.014

2.  Particle-to-PFU ratio of Ebola virus influences disease course and survival in cynomolgus macaques.

Authors:  Kendra J Alfson; Laura E Avena; Michael W Beadles; Hilary Staples; Jerritt W Nunneley; Anysha Ticer; Edward J Dick; Michael A Owston; Christopher Reed; Jean L Patterson; Ricardo Carrion; Anthony Griffiths
Journal:  J Virol       Date:  2015-07       Impact factor: 5.103

3.  Viral concentration determination through plaque assays: using traditional and novel overlay systems.

Authors:  Alan Baer; Kylene Kehn-Hall
Journal:  J Vis Exp       Date:  2014-11-04       Impact factor: 1.355

4.  Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures.

Authors:  Krisztina Janosko; Michael R Holbrook; Ricky Adams; Jason Barr; Laura Bollinger; Je T'aime Newton; Corrie Ntiforo; Linda Coe; Jiro Wada; Daniela Pusl; Peter B Jahrling; Jens H Kuhn; Matthew G Lackemeyer
Journal:  J Vis Exp       Date:  2016-10-03       Impact factor: 1.355

5.  Plaque assay for murine norovirus.

Authors:  Mariam B Gonzalez-Hernandez; Juliana Bragazzi Cunha; Christiane E Wobus
Journal:  J Vis Exp       Date:  2012-08-22       Impact factor: 1.355

Review 6.  The impact of regulations, safety considerations and physical limitations on research progress at maximum biocontainment.

Authors:  Amy C Shurtleff; Nicole Garza; Matthew Lackemeyer; Ricardo Carrion; Anthony Griffiths; Jean Patterson; Samuel S Edwin; Sina Bavari
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

Review 7.  Standardization of the filovirus plaque assay for use in preclinical studies.

Authors:  Amy C Shurtleff; Julia E Biggins; Ashley E Keeney; Elizabeth E Zumbrun; Holly A Bloomfield; Ana Kuehne; Jennifer L Audet; Kendra J Alfson; Anthony Griffiths; Gene G Olinger; Sina Bavari
Journal:  Viruses       Date:  2012-12-06       Impact factor: 5.048

  7 in total
  6 in total

1.  Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 3. Aerobiology.

Authors:  J Kyle Bohannon; Krisztina Janosko; Michael R Holbrook; Jason Barr; Daniela Pusl; Laura Bollinger; Linda Coe; Lisa E Hensley; Peter B Jahrling; Jiro Wada; Jens H Kuhn; Matthew G Lackemeyer
Journal:  J Vis Exp       Date:  2016-10-03       Impact factor: 1.355

2.  Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 4. Medical Imaging Procedures.

Authors:  Russell Byrum; Lauren Keith; Christopher Bartos; Marisa St Claire; Matthew G Lackemeyer; Michael R Holbrook; Krisztina Janosko; Jason Barr; Daniela Pusl; Laura Bollinger; Jiro Wada; Linda Coe; Lisa E Hensley; Peter B Jahrling; Jens H Kuhn; Margaret R Lentz
Journal:  J Vis Exp       Date:  2016-10-03       Impact factor: 1.355

3.  The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors.

Authors:  Yu-Jin Kim; Beatrice Cubitt; Emily Chen; Mitchell V Hull; Arnab K Chatterjee; Yingyun Cai; Jens H Kuhn; Juan C de la Torre
Journal:  Antiviral Res       Date:  2019-07-11       Impact factor: 5.970

4.  Cranial Vena Cava Syndrome in Guinea Pigs with Chronic Jugular Vein Catheters.

Authors:  Timothy K Cooper; Russell A Byrum; Kurt Cooper; Lisa Evans DeWald; Nina M Aiosa; Irwin M Feuerstein; Marisa C St Claire
Journal:  Comp Med       Date:  2020-01-16       Impact factor: 0.982

5.  Recombinant Lassa Virus Expressing Green Fluorescent Protein as a Tool for High-Throughput Drug Screens and Neutralizing Antibody Assays.

Authors:  Yíngyún Caì; Masaharu Iwasaki; Brett F Beitzel; Shuīqìng Yú; Elena N Postnikova; Beatrice Cubitt; Lisa Evans DeWald; Sheli R Radoshitzky; Laura Bollinger; Peter B Jahrling; Gustavo F Palacios; Juan C de la Torre; Jens H Kuhn
Journal:  Viruses       Date:  2018-11-20       Impact factor: 5.818

6.  Novel Dihydroorotate Dehydrogenase Inhibitors with Potent Interferon-Independent Antiviral Activity against Mammarenaviruses In Vitro.

Authors:  Yu-Jin Kim; Beatrice Cubitt; Yingyun Cai; Jens H Kuhn; Daniel Vitt; Hella Kohlhof; Juan C de la Torre
Journal:  Viruses       Date:  2020-07-29       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.